supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
drug:
Neuropeptide Y
supplement:
Polypeptides
Research Papers that Mention the Interaction
“Human PP inhibited binding with a Ki of 0.023 nM, whereas human PYY (Ki = 0.31 nM) and human NPY Ki = 12 nM) were significantly less potent.”
Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.“The pretreatment of NPY (18-36), an antagonist for NPY Y3 receptor, markedly attenuated the stimulation of ANP release by PP but did not affect the suppression of ANP release by PYY.”
Different Regulation of Atrial ANP Release through Neuropeptide Y2 and Y4 Receptors“The data show that the effects of NPY plus NPY 3-36 or NPY 3-36 plus PP were less than additive.”
“ Neuropeptide Y , but not galanin, significantly reduced the secretory responses to vasoactive intestinal polypeptide and bethanechol.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback